The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention
Authors:
- Pil Sang SongPSPil Sang Song
- Seok-Woo SeongSSSeok-Woo Seong
- Ji-Yeon KimJKJi-Yeon Kim
- Soo Yeon AnSASoo Yeon An
- Mi Joo KimMKMi Joo Kim
- Kye Taek AhnKAKye Taek Ahn
- Seon-Ah JinSJSeon-Ah Jin
- Jin-Ok JeongJJJin-Ok Jeong
- Jeong Hoon YangJYJeong Hoon Yang
- Joo-Yong HahnJHJoo-Yong Hahn
- Hyeon-Cheol GwonHGHyeon-Cheol Gwon
- Woo Jin JangWJWoo Jin Jang
Open Access
- 1 January 2024
- journal article
- research article
- Published by XMLink in Korean Circulation Journal
- Vol. 54 (4) , 189-200
Abstract
Song PS, et al. Korean Circ J. 2024 Apr;54(4):189-200. https://doi.org/10.4070/kcj.2023.0268Keywords
Funding Information
- Chungnam National University
This publication has 26 references indexed in Scilit:
- Trial Design Principles for Patients at High Bleeding Risk Undergoing PCIJACC, 2020
- A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial FibrillationThe American Journal of Cardiology, 2020
- 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationEuropean Heart Journal, 2020
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromesEuropean Heart Journal, 2019
- Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk ScoresJournal of the American Heart Association, 2018
- Rationale and design of the comparison between a P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients undergoing implantation of coronary drug-eluting stents (SMART-CHOICE): A prospective multicenter randomized trialAmerican Heart Journal, 2018
- Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCIJACC, 2016
- In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregationJournal of Thrombosis and Haemostasis, 2010
- Reduction of platelet thromboxane A2 production ex vivo and in vivo by clopidogrel therapyJournal of Thrombosis and Haemostasis, 2010
- Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectivenessThrombosis and Haemostasis, 2009